UnknownNot Applicable

Endometrial Compaction in Assissted Reproduction

Egypt145 participantsStarted 2021-08-20

Plain-language summary

To record the dynamic change of endometrial thickness (Day of embryo transfer Versus. Day of ovulation trigger administration in case of fresh cycles or end of estrogen phase in frozen cycles), and to investigate the impact of endometrial thickness change on pregnancy outcomes

Who can participate

Age range

18 Years – 40 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * • Infertile women aged 18 years to 40 years undergoing IVF/ ICSI for any indication. Exclusion Criteria: * • History of recurrent pregnancy loss (≥ 2 spontaneous abortions) and/or history of recurrent (≥ 2) ICSI failure after embryo transfer. * Uterine malformations. * Uncorrected hydrosalpinx. * Intrauterine conditions affecting pregnancy outcomes such as ( intrauterine adhesions, fibroids, polyps). * Any previous hysteroscopic surgery eg. Metroplasty or hysteroscopic myomectomy or uterine surgeries involving the endometrium eg. myomectomy during which uterine cavity was opened. * History suggesting endometritis. * Use of hCG for endometrial preparation or luteal phase support. * Poor quality embryos( according to Istanbul consensus workshop on embryo assessment )

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Ongoing pregnancy rate

Timeframe: 12 weeks after embryo transfer if hCG tested positive

Trial details

NCT IDNCT04962789

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-08-01

Contact for this trial

Ayman Askar, master

0020101 901 4640 aaaaskar@yahoo.com

View on ClinicalTrials.gov More Infertility, Female trials